What type of study is this?

This is a Literature Review study.

September 10, 2025Expert Review of Clinical Immunology

The JAK/STAT conundrum with mutational heterogeneity, immune defects, and the emergence of targeted therapies

View Full Paper

Ask AI

Bookmark

Authors

DDDurmuş Burak DemirkayaAhi Evran University BCBurkay Cagan ColakMarmara University ASAsena Pınar SeferRecep Tayyip Erdoğan University

Discussion

Member takes

Implication

This review demonstrates the impact of JAK/STAT pathway mutations on immune defects, suggesting targeted therapies may improve precision medicine in treatment.

Key Points

Dysregulation of the JAK/STAT pathway leads to immune defects and various disorders, highlighting its clinical significance.
Recent therapies focusing on JAK inhibitors have shown promising outcomes, enhancing treatment options for related diseases.
A bibliographic search encompassed articles until June 2025, providing a comprehensive overview of JAK/STAT protein functions.
Advances in molecular understanding of the JAK/STAT pathway may enable more precise therapeutic strategies for affected patients.

Cite This Study

Demirkaya et al. (2025) studied this question.

synapsesocial.com/papers/68c1ce7b54b1d3bfb60f5dce https://doi.org/10.1080/1744666x.2025.2543475

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates the impact of JAK/STAT pathway mutations on immune defects, suggesting targeted therapies may improve precision medicine in treatment.

The JAK/STAT conundrum with mutational heterogeneity, immune defects, and the emergence of targeted therapies

Discussion

Member takes

Implication

Key Points

Cite This Study

The JAK/STAT conundrum with mutational heterogeneity, immune defects, and the emergence of targeted therapies

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider